Tenders Are Invited For Delivery Of Antitumor Medicinal Products For The Needs Of Sbalo Sveti Mina Eood, Blagoevgrad - First Part By Specific Positions

The Subject Of The Public Procurement Supply Of Antitumor Medicinal Products For The Needs Of Sbalo Sveti Mina Eood, Blagoevgrad - First Part By Separate Positions Is Divided Into 5 /Five/ Separate Positions As Follows: Separate Position No. 1 Pemigatinib - Medicinal Product With Anatomic-Therapeutic Code /Ats-Code/ L01en02, International Non-Proprietary Name /Inn/ Pemigatinib, Pharmaceutical Form Tablet, Amount Of Active Substance 4.5 Mg, Estimated Amount 1,512 Tabl; Separate Position No. 2 Avapritinib - Medicinal Product With Anatomic-Therapeutic Code /Ats-Code/ L01ex18, International Non-Proprietary Name /Inn/ Avapritinib, Pharmaceutical Form Film-Coated Tablet, Amount Of Active Substance 100 Mg; Estimated Quantity 720 Tabl; Separate Position No. 3 Ripretinib - Medicinal Product With Anatomic-Therapeutic Code /Ats-Code/ L01ex19, International Non-Proprietary Name /Inn/ Ripretinib, Pharmaceutical Form Tablet, Amount Of Active Substance 50 Mg, Estimated Amount 1,080 Tabl; Separate Position No. 4 Tremelimumab, Amount Of Active Substance 300 Mg/15 Ml (20 Mg/Ml) - Medicinal Product With Anatomic-Therapeutic Code /Ats-Code/L01fx20, International Non-Proprietary Name /Inn/ Tremelimumab, Pharmaceutical Form Concentrate For Solution For Infusion, Amount Of Active Substance 300 Mg/15 Ml (20 Mg/Ml), Estimated Amount 4 Flac Separate Item No. 5 Tremelimumab, Amount Of Active Substance 25 Mg/1.25 Ml (20 Mg/Ml) - Medicinal Product With Anatomic-Therapeutic Code /Ats-Code/L01fx20, International Non-Proprietary Name /Inn/ Tremelimumab, Pharmaceutical Form Concentrate For Solution For Infusion, Amount Of Active Substance 25 Mg/1.25 Ml (20 Mg/Ml), Estimated Amount 60 Fl